GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hansen Medical Inc (NAS:HNSN) » Definitions » Gross Margin %

Hansen Medical (Hansen Medical) Gross Margin % : 31.76% (As of Mar. 2016)


View and export this data going back to 2006. Start your Free Trial

What is Hansen Medical Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Hansen Medical's Gross Profit for the three months ended in Mar. 2016 was $0.97 Mil. Hansen Medical's Revenue for the three months ended in Mar. 2016 was $3.04 Mil. Therefore, Hansen Medical's Gross Margin % for the quarter that ended in Mar. 2016 was 31.76%.


The historical rank and industry rank for Hansen Medical's Gross Margin % or its related term are showing as below:


HNSN's Gross Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 53.37
* Ranked among companies with meaningful Gross Margin % only.

Hansen Medical had a gross margin of 31.76% for the quarter that ended in Mar. 2016 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Hansen Medical was 0.00% per year.


Hansen Medical Gross Margin % Historical Data

The historical data trend for Hansen Medical's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansen Medical Gross Margin % Chart

Hansen Medical Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.22 20.47 20.62 15.41 6.24

Hansen Medical Quarterly Data
Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.95 11.58 6.41 -17.88 31.76

Competitive Comparison of Hansen Medical's Gross Margin %

For the Medical Instruments & Supplies subindustry, Hansen Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansen Medical's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hansen Medical's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Hansen Medical's Gross Margin % falls into.



Hansen Medical Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Hansen Medical's Gross Margin for the fiscal year that ended in Dec. 2015 is calculated as

Gross Margin % (A: Dec. 2015 )=Gross Profit (A: Dec. 2015 ) / Revenue (A: Dec. 2015 )
=1 / 16.068
=(Revenue - Cost of Goods Sold) / Revenue
=(16.068 - 15.065) / 16.068
=6.24 %

Hansen Medical's Gross Margin for the quarter that ended in Mar. 2016 is calculated as


Gross Margin % (Q: Mar. 2016 )=Gross Profit (Q: Mar. 2016 ) / Revenue (Q: Mar. 2016 )
=1 / 3.042
=(Revenue - Cost of Goods Sold) / Revenue
=(3.042 - 2.076) / 3.042
=31.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Hansen Medical  (NAS:HNSN) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Hansen Medical had a gross margin of 31.76% for the quarter that ended in Mar. 2016 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Hansen Medical Gross Margin % Related Terms

Thank you for viewing the detailed overview of Hansen Medical's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansen Medical (Hansen Medical) Business Description

Traded in Other Exchanges
N/A
Address
Hansen Medical Inc, formerly known as AutoCath Inc, was incorporated in Delaware in 2002. The Company completed its initial public offering on February 28, 2014. The Company develops, manufactures and sells medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System, Magellan Robotic System, Artisan catheter, Lynx catheter, Magellan Robotic Catheter, and CoHesion 3D Visualization Module. Sensei Robotic Catheter System, or Sensei system, is designed to allow physicians to navigate flexible catheters with solid stability and control in interventional procedures within the atrial heart chambers. This system enables physicians to direct the movements of a robotic catheter like the Company's Artisan Control Catheter and Artisan Extend Control Catheter, or Artisan catheters, and Lynx Robotic Ablation Catheter, or Lynx catheter, to an anatomical location. The Sensei system is comprised of two modules: a physician control console and a patient-side module that can be connected to procedure tables. The control console can be located inside the Electro-Physiology Laboratory, or EP lab, and close to the patient or outside the EP lab in a separate location shielded from radiation. The Company's Magellan Robotic System is a peripheral vascular interventional platform that, used in combination with the Magellan Robotic Catheters, has the potential to provide endovascular specialists with vessel navigation, catheter stability during the manual delivery and placement of therapeutic devices, reduced procedural radiation exposure and fatigue, and precise robotic control of distal catheter tips. Magellan Robotic System is comprised of two modules: a physician control console and a patient-side robotic arm that can be connected to procedure tables. The Artisan catheter is a disposable catheter and guide catheter assembly that consists of a telescoping set of control catheters that are integrated to provide the desired motion of the tip of a diagnostic or therapeutic catheter that is inserted through the center lumen of the Artisan catheter. This is designed to accurately control the movement of a third party catheter chosen by the physician. CoHesion 3D Visualization Module, or CoHesion Module, is a software interface between Sensei system and the St. Jude Medical EnSite System for EP procedures. It is designed to provide physicians with 3D visualization to augment their ability to move a catheter throughout the atria, as well as increase control over placement of the catheter in specific locations. The Company markets, sells and supports its products in the United States through a direct sales force of regional sales employees, supported by clinical account managers who provide training, clinical support and other services to customers. Outside the United States, in the European Union, it uses a combination of a direct sales for
Executives
William R Rohn director PO BOX 676367, RANCHO SANTA FE CA 92067
Christopher P. Lowe director, officer: Interim CFO 2511 N LOOP 1604,, SUITE 204, SAN ANTONIO TX 78258
Oracle Institutional Partners L P 10 percent owner 200 GREENWICH AVENUE, 3RD FLOOR, GREENWICH CT 06830
Oracle Partners Lp 10 percent owner 200 GREENWICH AVE, 3RD FL, GREENWICH CT 06830
Larry N Feinberg 10 percent owner C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Oracle Associates Llc 10 percent owner 200 GREENWICH AVENUE, 3RD FLOOR, GREENWICH CT 06830
Stephen L Newman director 13737 NOEL ROAD, SUITE 100, DALLAS TX 75093
Oracle Ten Fund Master, Lp 10 percent owner C/O ORACLE INVESTMENT MANAGEMENT, INC., 200 GREENWICH AVENUE, GREENWICH CT 06830
Jack W. Schuler Living Trust other: Former 10% Owner 100 NORTH FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Family Foundation Schuler other: Former 10% Owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Marjorie L. Bowen director 225 6TH STREET, MANHATTAN BEACH CA 90266
Jack W Schuler director, 10 percent owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Peter J Mariani officer: Chief Financial Officer C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Bruce Barclay director
Russell C Hirsch director 435 TASSO STREET, SUITE 200, PALO ALTO CA 94301